Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (44)

2023

  1. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Annals of Oncology, Vol. 34, Núm. 8, pp. 645-659

  2. Magnetic resonance imaging reference values for cardiac morphology, function and tissue composition in adolescents

    eClinicalMedicine, Vol. 57

  3. Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 1, pp. 67-80

2022

  1. Post-Myocardial Infarction Risk Prediction: Does Ventricular Shape Matter?

    JACC: Cardiovascular Imaging

  2. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Beta-blocker therapy in elderly patients with renal dysfunction and heart failure

    Journal of Geriatric Cardiology, Vol. 18, Núm. 1, pp. 20-29

  2. Clinical Validation of a 3-Dimensional Ultrafast Cardiac Magnetic Resonance Protocol Including Single Breath-Hold 3-Dimensional Sequences

    JACC: Cardiovascular Imaging, Vol. 14, Núm. 9, pp. 1742-1754

  3. Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 870-877

  4. Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study

    Basic Research in Cardiology, Vol. 116, Núm. 1

  5. PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease

    Journal of Cardiovascular Translational Research, Vol. 14, Núm. 2, pp. 238-245

  6. Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the geicam/2015-04 (Pangea-breast) study

    Cancers, Vol. 13, Núm. 21

  7. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity

    Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143

  8. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

  9. Time-efficient three-dimensional transmural scar assessment provides relevant substrate characterization for ventricular tachycardia features and long-term recurrences in ischemic cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

  2. Calcified plaques in the radial artery: OCT insight

    REC: Interventional Cardiology

  3. Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 133, pp. 39-47

  4. Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy)

    Journal of Cardiovascular Magnetic Resonance, Vol. 22, Núm. 1

  5. Metoprolol blunts the time-dependent progression of infarct size

    Basic Research in Cardiology, Vol. 115, Núm. 5

  6. Reimagining global oncology clinical trials for the postpandemic era: A call to arms

    JCO Global Oncology, pp. 1357-1362